About this trial
Meniscopathy surgeries are commonly associated with moderate postoperative pain, particularly during early mobilization and rehabilitation. Inadequate postoperative analgesia may negatively affect functional recovery, delay ambulation, increase opioid consumption, and contribute to opioid-related adverse effects. Therefore, effective multimodal analgesic strategies are of considerable importance in patients undergoing arthroscopic knee procedures.
Adductor canal block (ACB) is a widely used regional anesthesia technique that provides effective analgesia while largely preserving quadriceps muscle strength. However, its limited effect on posterior knee capsule innervation may result in insufficient control of posterior knee pain. Recently, the biceps femoris short head (BiFeS) block has been described as a novel motor-sparing fascial plane block targeting the posterolateral knee capsule and may provide additional analgesic benefit when combined with ACB.
In this study, it was aimed to compare the postoperative analgesic efficacy of adductor canal block alone and adductor canal block combined with BiFeS block in patients undergoing surgery for meniscopathy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged 18-65 years
American Society of Anesthesiologists (ASA) score I-II-III
Body Mass Index (BMI) between 18-30 kg/m2
Disqualifiers
Patients under 18 and over 65 years of age
ASA score IV and above
Patients with a history of bleeding diathesis
BMI below 18 or above 30 kg/m2
Trial design
Parallel
Treatments tested in this trial
Adductor Canal Block Group
Procedure/SurgeryAdductor canal block will be performed on the patients using 10 ml of 0.25% bupivacaine under ultrasound guidance. Additionally, in the postoperative period a paracetamol dose of 1 g every 8 hours and a dexketoprofen dose of 50 mg twice daily were administered iv for multimodal analgesia.
Adductor Canal Block + BiFeS (Biceps Femoris Short Head) Block Group
Procedure/SurgeryIn the adductor canal block + BiFeS block group, adductor canal block will be performed using 10 ml of 0.25% bupivacaine, followed by BiFeS block using 20 ml of 0.25% bupivacaine under ultrasound guidance, with a total local anesthetic volume of 30 ml. Additionally, in the postoperative period a paracetamol dose of 1 g every 8 hours and a dexketoprofen dose of 50 mg twice daily were administered iv for multimodal analgesia.
Control Group
Procedure/SurgeryIn the postoperative period a paracetamol dose of 1 g every 8 hours and a dexketoprofen dose of 50 mg twice daily were administered iv for multimodal analgesia.
Treatment groups
Trial outcomes
Primary outcomes
Pain Scores
Pain will be assessed at rest and while coughing using the visual analog scale on a scale from 0 (no pain) to 100 (worst pain). Pain assessment will be done at 0st, 1st, 2nd,4th, 12th, and 24th hours after surgery.
Secondary outcomes
Total Postoperative Morphine Consumption During the First 24 Hours After Surgery
Total Postoperative Morphine Consumption During the First 24 Hours After Surgery
Sponsors and contacts
Click on the lead sponsor to view all of their trials.